Perez-Chacon G, Santamaria P, Redondo-Pedraza J, Gonzalez-Suarez E
Adv Exp Med Biol. 2025; 1464():309-345.
PMID: 39821032
DOI: 10.1007/978-3-031-70875-6_16.
Song C, Tong T, Dai B, Zhu Y, Chen E, Zhang M
J Natl Cancer Cent. 2024; 4(4):354-368.
PMID: 39735445
PMC: 11674455.
DOI: 10.1016/j.jncc.2024.09.001.
Espana-Pamplona P, Bernes-Martinez L, Andres-Castello C, Bolas-Colvee B, Adobes-Martin M, Garcovich D
J Clin Med. 2024; 13(23).
PMID: 39685893
PMC: 11642593.
DOI: 10.3390/jcm13237435.
Peng B, Wang L, Han G, Cheng Y
Stem Cell Res Ther. 2024; 15(1):342.
PMID: 39354604
PMC: 11446149.
DOI: 10.1186/s13287-024-03962-3.
Xuan Z, Chen X, Zhou W, Shen Y, Sun Z, Zhang H
Front Immunol. 2024; 15:1367958.
PMID: 39055710
PMC: 11269137.
DOI: 10.3389/fimmu.2024.1367958.
XAF1 promotes osteoclast apoptosis by antagonizing the XIAP-caspase axis.
Zhang M, Huang Y, Bai J, Xu W, Shan H, Sheng L
J Orthop Translat. 2024; 47:15-28.
PMID: 38957269
PMC: 11217565.
DOI: 10.1016/j.jot.2024.05.001.
Is there a role for essential fatty acids in osteoporosis?.
Das U
Eur J Clin Nutr. 2024; 78(8):659-662.
PMID: 38840032
DOI: 10.1038/s41430-024-01456-2.
(Fr.) Singer β-1,3-Glucanoligosaccharide (Ps-GOS) Suppresses RANKL-Induced Osteoclast Differentiation and Function in Pre-Osteoclastic RAW 264.7 Cells by Inhibiting the RANK/NFκB/cFOS/NFATc1 Signalling Pathway.
Rattajak P, Aroonkesorn A, Smythe C, Wititsuwannakul R, Pitakpornpreecha T
Molecules. 2024; 29(9).
PMID: 38731604
PMC: 11085266.
DOI: 10.3390/molecules29092113.
Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues.
Chen W, Wang Q, Tao H, Lu L, Zhou J, Wang Q
Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):499-512.
PMID: 38439665
PMC: 11090848.
DOI: 10.3724/abbs.2024017.
NF-κB in biology and targeted therapy: new insights and translational implications.
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M
Signal Transduct Target Ther. 2024; 9(1):53.
PMID: 38433280
PMC: 10910037.
DOI: 10.1038/s41392-024-01757-9.
Distinct cross talk of IL-17 & TGF-β with the immature CD11c TRAF6 -null myeloid dendritic cell-derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo.
Liu Y, Teng A
Immun Inflamm Dis. 2024; 12(2):e1173.
PMID: 38415924
PMC: 10851637.
DOI: 10.1002/iid3.1173.
The hagfish genome and the evolution of vertebrates.
Marletaz F, Timoshevskaya N, Timoshevskiy V, Parey E, Simakov O, Gavriouchkina D
Nature. 2024; 627(8005):811-820.
PMID: 38262590
PMC: 10972751.
DOI: 10.1038/s41586-024-07070-3.
Modulation of fracture healing by senescence-associated secretory phenotype (SASP): a narrative review of the current literature.
Zhao S, Qiao Z, Pfeifer R, Pape H, Mao K, Tang H
Eur J Med Res. 2024; 29(1):38.
PMID: 38195489
PMC: 10775505.
DOI: 10.1186/s40001-023-01604-7.
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health.
Guimaraes G, Coelho J, Silva J, de SantAna A, de Sa C, Moreno J
Osteoporos Int. 2023; 35(4):575-588.
PMID: 38055051
DOI: 10.1007/s00198-023-06991-5.
Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms.
Joseph G, Johnson D, Johnson R
J Bone Oncol. 2023; 43:100505.
PMID: 37842554
PMC: 10568292.
DOI: 10.1016/j.jbo.2023.100505.
Microenvironment-targeted strategy steers advanced bone regeneration.
Hao S, Wang M, Yin Z, Jing Y, Bai L, Su J
Mater Today Bio. 2023; 22:100741.
PMID: 37576867
PMC: 10413201.
DOI: 10.1016/j.mtbio.2023.100741.
Giant Cells of Various Lesions Are Characterised by Different Expression Patterns of HLA-Molecules and Molecules Involved in the Cell Cycle, Bone Metabolism, and Lineage Affiliation: An Immunohistochemical Study with a Review of the Literature.
Hild V, Mellert K, Moller P, Barth T
Cancers (Basel). 2023; 15(14).
PMID: 37509363
PMC: 10377796.
DOI: 10.3390/cancers15143702.
Role of Iron Accumulation in Osteoporosis and the Underlying Mechanisms.
Li G, Gao Y, Weinberg E, Huang X, Xu Y
Curr Med Sci. 2023; 43(4):647-654.
PMID: 37326889
DOI: 10.1007/s11596-023-2764-z.
The Molecular Mechanisms Study of Engeletin Suppresses RANKL-Induced Osteoclastogenesis and Inhibits Ovariectomized Murine Model Bone Loss.
Feng M, Liu L, Wang J, Zhang J, Qu Z, Wang Y
J Inflamm Res. 2023; 16:2255-2270.
PMID: 37250105
PMC: 10225148.
DOI: 10.2147/JIR.S401519.
Targeting strategies for bone diseases: signaling pathways and clinical studies.
Xu H, Wang W, Liu X, Huang W, Zhu C, Xu Y
Signal Transduct Target Ther. 2023; 8(1):202.
PMID: 37198232
PMC: 10192458.
DOI: 10.1038/s41392-023-01467-8.